
Keep a close watch on the private company behind the David Bar for a potential Initial Public Offering (IPO), as its founder previously sold RX Bar for $600 million. The company has a significant competitive advantage after acquiring Epigee, the owner of its patented low-calorie fat ingredient, EPG. This strategic move secures its unique high-protein, low-calorie formula that has driven explosive initial sales. To capitalize on the broader "protein boom" trend, consider investing in public consumer goods and ingredient technology companies. Focus on firms that are successfully innovating to improve the protein-to-calorie ratio in their products, as this is the key to winning market share.

By The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp